731 results on '"De Ferrari, Gaetano M."'
Search Results
52. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
53. Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR
54. OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT
55. Safety and Efficacy of Bempedoic Acid: A Systematic Review and Metanalysis of Randomised Controlled Trials
56. Current challenges for clinical trials of cardiovascular medical devices
57. Left main coronary artery external compression by lung adenocarcinoma successfully treated with percutaneous coronary intervention
58. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
59. Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis.
60. SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registry
61. Remote Ischemic Post-Conditioning of the Lower Limb During Primary Percutaneous Coronary Intervention Safely Reduces Enzymatic Infarct Size in Anterior Myocardial Infarction: A Randomized Controlled Trial
62. Abstract 20851: Incidence of Appropriate ICD Therapies After Elective Generator Replacement in Patient With Heart Failure Initially Implanted for Primary Prevention: A Systematic Literature Review and Metanalysis
63. Abstract 18503: Preliminary Results From the Multicenter International Registry on Electrical Storm Patients: The ELECTRA Study
64. Abstract 16714: Characterization of Types and Sizes of Myocardial Infarction Reduced With Evolocumab in FOURIER
65. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes
66. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
67. Torsades de pointes following acute myocardial infarction: Evidence for a deadly link with a common genetic variant
68. Role of the Autonomic Nervous System in Sustained Ventricular Tachycardia after Myocardial Infarction
69. Use of baroreceptor reflex sensitivity in the prediction of risk after myocardial infarction
70. Valve‐in‐valve transcatheter aortic valve replacement or re‐surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta‐analysis of short and midterm results
71. Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure
72. Excess all-cause mortality during COVID-19 outbreak: potential role of untreated cardiovascular disease
73. Machine learning for cardiology
74. Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis
75. Rapid Recovery of Baroreceptor Reflexes in Acute Myocardial Infarction is a Marker of Effective Tissue Reperfusion
76. Vagal Stimulation in Heart Failure
77. Left Cardiac Sympathetic Denervation in Patients with Heart Failure: a New Indication for an Old Intervention?
78. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis.
79. Vagal Stimulation in Heart Failure: An Anti-inflammatory Intervention?
80. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: The surgical supraclavicular approach to cervicothoracic sympathectomy
81. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis
82. Percutaneous or Surgical Access for Transfemoral Transcatheter Aortic Valve Implantation: A Propensity Matched Analysis of a Multicenter Registry
83. Sodium Nitroprusside in Acute Heart Failure: A Multicenter Historic Cohort Study
84. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
85. Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis
86. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
87. Vagal stimulation for heart failure: Background and first in-man study
88. T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation?
89. SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry.
90. What will we ask to artificial intelligence for cardiovascular medicine in the next decade?
91. Novel Non-pharmacological Approaches to Heart Failure
92. Sympathetic–parasympathetic interaction in health and disease: abnormalities and relevance in heart failure
93. Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions
94. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial
95. Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction
96. Vox clamantis in deserto. We spoke but nobody was listening: echocardiography can help risk stratification of the long-QT syndrome
97. Trials of implantable monitoring devices in heart failure: which design is optimal?
98. Leptin affects the inflammatory response after STEMI
99. Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF
100. Cardiovascular disease burden: Italian and global perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.